Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity in human primary immunodeficiency diseases.

Peter D Arkwright1, Mario Abinun, Andrew J Cant

  • 1Academic Unit of Child Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom. peter_arkwright@lineone.net

Blood
|April 4, 2002
PubMed
Summary

Primary immunodeficiency diseases increase infection risk and autoimmune complications. Understanding their molecular basis aids in developing targeted treatments for these complex conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder.

Frontiers in immunology·2026
Same author

Blood IL-6 is a critical trigger of depressive symptoms in a mouse model for human atopic dermatitis.

Translational psychiatry·2026
Same author

Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Journal of asthma and allergy·2026
Same author

Soluble bacterial lipopeptides suppress gasdermin D-associated IL-33 release in keratinocytes and atopic dermatitis in mice.

Nature communications·2026
Same author

Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.

American journal of clinical dermatology·2026
Same author

Recessive loss of DIAPH1 function causes a progressive neurodevelopmental syndrome with variable immunological involvement.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Area of Science:

  • Immunology
  • Genetics
  • Clinical Medicine

Background:

  • Primary immunodeficiency diseases (PIDs) manifest as heightened susceptibility to infections.
  • These conditions frequently present with severe autoimmune complications.
  • Recent advancements illuminate the molecular underpinnings of PIDs.

Purpose of the Study:

  • To catalogue the diverse autoimmune phenomena in human PIDs.
  • To investigate the mechanisms by which PIDs predispose to autoimmunity, especially post-infection.
  • To evaluate current treatment strategies for autoimmune issues in PIDs.

Main Methods:

  • Literature review of primary immunodeficiency diseases and associated autoimmunity.
  • Analysis of molecular mechanisms linking PIDs to autoimmune complications.

Related Experiment Videos

  • Synthesis of current therapeutic approaches for autoimmune manifestations in PIDs.

    • Main Results:

    • PIDs exhibit a wide spectrum of autoimmune disorders.
    • Opportunistic infections can trigger or exacerbate autoimmunity in PID patients.
    • Understanding specific genetic defects offers insights into autoimmune pathogenesis.

    Conclusions:

    • Elucidating the genetic basis of autoimmunity in PIDs is crucial.
    • This knowledge can inform novel therapeutic strategies for idiopathic autoimmune diseases.
    • Targeted treatments for PIDs-associated autoimmunity may improve patient outcomes.